Low-dose aspirin in polycythaemia vera: A pilot study

T. Barbui, G. de Gaetano, G. Finazzi, Raffaele Landolfi, R. Marchioli, C. Patrono, G. Tognoni, F. Capani, A. De Carli, D. Gambi, G. G. Nenci, S. Tura, F. Mandelli, P. Rossi-Ferrini, T. Barbui, S. Cortelazzo, G. Finazzi, O. Vestri, S. Tura, C. FinelliF. Nocentini, E. M. Pogliani, I. R. Miccolis, B. Bizzi, B. Rocca, R. Tartagilione, G. Angeli, A. Di Blasio, A. Di Pasquale, V. Kramer, R. M. Marfisi, M. Olivieri, L. Sciulli, R. Spoltore, F. Mandelli, E. Montefusco, A. Spadea, M. Carotenuto, M. Nobile, A. Morelli, L. Resegotti, M. A. Ciocca Vasino, F. Rodeghiero, M. Ruggeri, Gruppo Italiano Studio Policitemia (GISP)

Research output: Contribution to journalArticlepeer-review


In this pilot study, aimed at exploring the feasibility of a large-scale trial of low-dose aspirin in polycythaemia vera (PV), 112 PV patients (42 females, 70 males, aged 17-80 years) were selected for not having a clear indication for, or contraindication to, aspirin treatment and randomized to receive oral aspirin (40 mg/d) or placebo. Follow-up duration was 16 ± 6 months. Measurements of thromboxane A2 production during whole blood clotting demonstrated complete inhibition of platelet cyclooxygenase activity in patients receiving aspirin. Aspirin administration was not associated with any bleeding complication. Within the limitations of the small sample size, this study indicates that a biochemically effective regimen of antiplatelet therapy is well tolerated in patients with polycythaemia vera and that a large-scale placebo-controlled trial is feasible.

Original languageEnglish
Pages (from-to)453-456
Number of pages4
JournalBritish Journal of Haematology
Issue number2
Publication statusPublished - 1997


  • Antiplatelet treatment
  • Aspirin
  • Polycythaemia vera
  • Randomized clinical trial
  • Thromboxane

ASJC Scopus subject areas

  • Medicine(all)
  • Hematology


Dive into the research topics of 'Low-dose aspirin in polycythaemia vera: A pilot study'. Together they form a unique fingerprint.

Cite this